BRIEF published on 04/29/2025 at 14:05, 1 year 1 month ago Bausch Health Secures Health Canada Approval for Thermage FLX Thermage FLX Bausch Health Health Canada Aesthetic Technology Skin Tightening
PRESS RELEASE published on 04/29/2025 at 14:00, 1 year 1 month ago Bausch Health Announces Health Canada Clearance of Solta Medical's Thermage(R) FLX System Health Canada approves Thermage FLX, the latest non-invasive skin tightening system from Bausch Health's Solta Medical. Features enhanced comfort, smart technology, and versatile applications Thermage FLX Bausch Health Health Canada Skin Tightening Solta Medical
BRIEF published on 04/25/2025 at 14:05, 1 year 2 months ago Bausch Health Unveils Advanced Skin Resurfacing Technology at ASLMS 2025 Bausch Health Aesthetic Medicine Fraxel FTX™ Skin Resurfacing ASLMS 2025
BRIEF published on 04/25/2025 at 14:05, 1 year 2 months ago Bausch Health dévoile une technologie avancée de resurfaçage cutané à l'ASLMS 2025 Bausch Santé Médecine Esthétique Fraxel FTX™ ASLMS 2025 Resurfaçage De La Peau
PRESS RELEASE published on 04/25/2025 at 14:00, 1 year 2 months ago Bausch Health Announces Launch of Solta Medical's Fraxel FTX(TM) Bausch Health unveiled Fraxel FTX™, the next-gen skin resurfacing tech, at ASLMS 2025, Orlando. Dual-wavelength laser treats skin concerns with visible results & minimal downtime Bausch Health Laser Technology Skin Resurfacing ASLMS 2025 Fraxel FTX
BRIEF published on 04/22/2025 at 13:30, 1 year 2 months ago Bausch Health dépose un supplément à sa circulaire de sollicitation de procurations suite aux échanges d'actions d'Icahn Droits Des Actionnaires Bausch Santé Swaps D'actions Carl Icahn Déclaration De Procuration
BRIEF published on 04/22/2025 at 13:30, 1 year 2 months ago Bausch Health Files Supplement to Proxy Statement Amid Icahn's Equity Swaps Proxy Statement Bausch Health Shareholder Rights Equity Swaps Carl Icahn
PRESS RELEASE published on 04/22/2025 at 13:25, 1 year 2 months ago Bausch Health Announces Filing of Supplement to Proxy Statement Bausch Health updates Proxy Statement to disclose 24.6% common shares held by Carl Icahn. Company adopts shareholder rights plan agreement to prevent 'creeping' take-over bids Proxy Statement Bausch Health Update Shareholder Rights Plan Carl Icahn
BRIEF published on 04/17/2025 at 21:45, 1 year 2 months ago Bausch Health Prevails in U.S. District Court Case Bausch Health Norwich Pharmaceuticals XIFAXAN® FDA Ruling Teva Exclusivity
BRIEF published on 04/17/2025 at 21:45, 1 year 2 months ago Bausch Health l'emporte devant un tribunal de district américain Bausch Santé Norwich Pharmaceuticals XIFAXAN® Décision De La FDA Exclusivité Teva
Published on 06/27/2026 at 16:50, 2 hours 15 minutes ago Redwood AI Announces Definitive Agreement with Quantum.IQ and Expands into Quantum Resistant Cyber Security
Published on 06/27/2026 at 01:40, 17 hours 25 minutes ago Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 19 hours 5 minutes ago Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 20 hours 5 minutes ago Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Published on 06/26/2026 at 22:50, 20 hours 15 minutes ago Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Published on 06/27/2026 at 00:05, 19 hours ago EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Published on 06/27/2026 at 00:04, 19 hours 1 minute ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 19 hours 29 minutes ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 19 hours 29 minutes ago EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
Published on 06/26/2026 at 23:27, 19 hours 38 minutes ago EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE
